nad+ coa

A verified NAD+ COA (Certificate of Analysis) provides institutional researchers with indispensable chemical data, confirming the exact purity, molecular identity, and sterility of Nicotinamide Adenine Dinucleotide. PX1 Research subjects every batch of NAD+ to independent HPLC mass-spectrometry and endotoxin screening to guarantee reproducible in vitro assay conditions.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

A verified NAD+ COA (Certificate of Analysis) provides institutional researchers with indispensable chemical data, confirming the exact purity, molecular identity, and sterility of Nicotinamide Adenine Dinucleotide. PX1 Research subjects every batch of NAD+ to independent HPLC mass-spectrometry and endotoxin screening to guarantee reproducible in vitro assay conditions.

Reviewed by PX1 Research scientific team

Key takeaways

  • In biochemical research, obtaining a detailed [NAD+](/research-peptides/nad-plus) COA is the primary prerequisite for ensuring experimental precision across enzymatic, cellular, and metabolic studies.
  • Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) represents the analytical gold standard for quantifying the purity of non-protein coenzymes and peptides.
  • While HPLC quantifies compound purity, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms unequivocal structural identity.
  • Bacterial endotoxins—specifically lipopolysaccharides (LPS) derived from Gram-negative cell walls—present a significant confounding variable in cell-based assays, primary tissue cultures, and physiological signal transduction models.

Understanding the NAD+ COA: Structural Identity and Chemical Specifications

In biochemical research, obtaining a detailed NAD+ COA is the primary prerequisite for ensuring experimental precision across enzymatic, cellular, and metabolic studies. Nicotinamide Adenine Dinucleotide (NAD+, C21H27N7O14P2) serves as a critical coenzyme in cellular redox reactions, cycling between its oxidized (NAD+) and reduced (NADH) states. When sourcing this nucleotide for laboratory applications, verifying chemical integrity via a lot-specific analytical report prevents baseline drift, false negatives in microplate reader assays, and unintended co-factor degradation.

A rigorous NAD+ COA details critical parameters including molecular weight (663.43 g/mol), visual appearance, chemical stability, solubility profiles, and quantitative purity. Because NAD+ is inherently hygroscopic and susceptible to hydrolysis into nicotinamide and ADP-ribose under ambient conditions, analytical documentation must reflect the state of the material immediately following lyophilization and atmosphere-controlled packaging. Facilities utilizing PX1 Research reagents gain full access to verified documentation generated by independent ISO 17025 accredited laboratories.

RP-HPLC Purity Analysis: Decoding Chromatographic Peak Integrity

Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) represents the analytical gold standard for quantifying the purity of non-protein coenzymes and peptides. A robust NAD+ COA must display a complete HPLC chromatogram demonstrating clear baseline separation, minimal peak broadening, and an absence of co-eluting impurites. In standard assay protocols, a C18 stationary phase paired with an phosphate-buffered mobile phase isolates NAD+ based on hydrophobic interactions and ion-pairing kinetics.

When inspecting chromatographic data on an analytical report, researchers should look for a primary peak area integrating to 98.0% or higher. Common degradation products—such as alpha-NAD+ stereoisomers, nicotinamide, or hydrolyzed mononucleotides—exhibit distinct retention times. Evaluating peak symmetry and total area percentages via third-party HPLC analytical validation ensures that competitive enzymatic inhibition does not interfere with target sirtuin or PARP functional assays.

Mass Spectrometry (ESI-MS) Verification of Nicotinamide Adenine Dinucleotide

While HPLC quantifies compound purity, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms unequivocal structural identity. A comprehensive NAD+ COA includes mass spectra depicting the observed mass-to-charge ratio (m/z) compared against the theoretical monoisotopic mass. For Nicotinamide Adenine Dinucleotide, the primary positive ionization peak [M+H]+ appears at m/z 664.4, with corresponding sodium adducts frequently identified in trace quantities.

Mass spectrometry analysis eliminates the risk of misidentified synthesis by-products or salt contamination that could skew quantitative assay concentration calculations. By cross-referencing HPLC retention times with MS spectral fingerprints, researchers can confirm structural authenticity prior to initiating complex cell culture or enzyme kinetic experiments. Detailed mass spectrometry documentation for all catalog items is accessible through our comprehensive research database.

Endotoxin Limits and Bioburden Control in NAD+ Research Reagents

Bacterial endotoxins—specifically lipopolysaccharides (LPS) derived from Gram-negative cell walls—present a significant confounding variable in cell-based assays, primary tissue cultures, and physiological signal transduction models. Even minute endotoxin contamination can trigger non-specific inflammatory signaling pathways, overriding normal metabolic responses. Consequently, a validated NAD+ COA must include quantitative endotoxin testing performed via standard Chromogenic Reagent Limulus Amebocyte Lysate (LAL) assays.

PX1 Research enforces strict bioburden parameters, guaranteeing that research reagents maintain endotoxin levels well below industry thresholds (<0.01 EU/mg). This level of quality control ensures that metabolic perturbations observed in cell culture models stem purely from the experimental variable rather than pyrogenic artifacts. Institutional purchasing departments can review these bioburden specifications across our full selection of high-purity research peptides.

Comparative Evaluation: NAD+ COA vs. NMN and Related Metabolic Coenzymes

When designing pathways assays targeting mitochondrial bioenergetics or metabolic flux, researchers often compare Nicotinamide Adenine Dinucleotide with precursor nucleotides and complementary cellular regulators. The analytical standards outlined in an NAD+ COA differ structurally from those required for precursor compounds due to variations in molecular weight, charge dynamics, and baseline stability.

For instance, evaluating an NAD+ COA alongside reports for NMN research materials reveals significant shifts in HPLC retention parameters and m/z spectral profiles (NMN displaying [M+H]+ at m/z 335.2). Similarly, when conducting parallel trials involving redox regulators like Glutathione 200mg reagent or peptide-based mitochondrial modulators such as SS-31 research peptide, distinct purity matrices and oxidation-state verifications must be documented per lot. Comprehensive analytical comparative data for these compounds can be further explored in our dedicated mitochondrial bioenergetics library.

Laboratory Reconstitution Protocols for NAD+ In Vitro Assays

Maintaining chemical stability following lyophilized reagent receipt requires adherence to standard laboratory reconstitution techniques. Solid-state NAD+ is stable under frozen storage conditions (-20°C), but once dissolved in aqueous media, hydrolysis kinetics accelerate as a function of temperature and pH. Researchers preparing working solutions should reconstitute lyophilized material using sterile, nuclease-free water or buffered saline (PBS) maintained between pH 6.0 and 7.0.

Because NAD+ is sensitive to alkaline degradation and thermal fluctuations, working aliquots should be prepared immediately following dissolution, snap-frozen in liquid nitrogen, and stored at -80°C to prevent auto-oxidation to NADH or enzymatic cleavage. Reconstituted stock solutions should avoid repeated freeze-thaw cycles, which introduce physical stresses that degrade nucleotide purity below the thresholds verified on the original lot COA.

Stability, Thermal Degradation, and Lyophilized Reagent Storage

To preserve the analytical integrity documented on a lot-specific COA, laboratory handling conditions must account for thermodynamic instability. Lyophilized NAD+ powder exhibits high stability when maintained in vacuum-sealed vials away from direct light exposure at -20°C. Degradation monitoring indicates that exposure to elevated ambient temperatures or atmospheric humidity causes rapid hydration, leading to sticky mass formation and accelerated chemical decay.

PX1 Research ships all reagents directly from climate-controlled fulfillment centers located in California and Arizona. Utilizing specialized thermal protective packaging and rapid transport guarantees that reagents arrive at research institutions without compromising chemical structure or exceeding baseline degradation limits established during post-synthesis quality control.

Quality Assurance: ISO 17025 Auditing and Lot Traceability

The credibility of an analytical document hinges on the independence and rigor of the testing facility. PX1 Research partners exclusively with ISO 17025 accredited analytical laboratories located within the United States. This accreditation mandates strict instrument calibration protocols, validated testing methods, and standardized reporting metrics that render every NAD+ COA audit-ready for academic, clinical, and industrial review.

Lot traceability is embedded into every step of our supply chain. Each physical vial features a lot-specific tracking number matching the accompanying analytical documentation. This transparent verification mechanism allows laboratory managers to verify batch-to-batch consistency, audit raw material inputs, and uphold compliance standards required by grant-funded research protocols and institutional oversight boards.

Procurement Standards for Institutional and Industrial Research Facilities

High-throughput screening laboratories, university biochemistry departments, and commercial biotechnology entities require consistent sourcing channels that prioritize analytical verification alongside supply chain reliability. Relying on unverified suppliers or non-certified materials risks introducing variable co-factor concentrations into critical enzymatic assays.

Through our specialized bulk procurement program, institutional partners receive dedicated account coordination, volume-based pricing tiers, and prioritized access to custom lot sizes accompanied by pre-shipment COA documentation. Combined with same-day dispatch for orders placed before standard cutoff times, PX1 Research provides the logistical infrastructure necessary to support uninterrupted empirical research.

Frequently Asked Questions

What information is included on a standard nad+ coa?

A standard NAD+ COA (Certificate of Analysis) provides lot-specific testing data including chemical name, molecular weight (663.43 g/mol), CAS number (53-84-9), RP-HPLC purity percentage, ESI-MS structural identity confirmation, appearance, solubility parameters, and quantitative LAL endotoxin test results.

Why is third-party HPLC testing critical for an nad+ coa?

RP-HPLC testing separates NAD+ from synthetic precursor residues, stereoisomers, and hydrolysis products like nicotinamide and ADP-ribose. A third-party HPLC report guarantees an objective purity measurement—typically 98.0% or higher—ensuring off-target compounds do not alter experimental assay outcomes.

How is ESI-MS used to verify NAD+ identity on a COA?

Electrospray Ionization Mass Spectrometry (ESI-MS) measures the mass-to-charge ratio (m/z) of the compound. The resulting spectrum displays a primary molecular ion peak corresponding to the theoretical mass of NAD+ ([M+H]+ at m/z 664.4), confirming structural identity beyond simple chromatographic retention time.

What endotoxin limits should be expected on a high-grade NAD+ COA?

For cell culture and in vitro biochemical research, endotoxin levels should ideally measure below 0.01 EU/mg as determined by a Limulus Amebocyte Lysate (LAL) assay. Low bioburden prevents inflammatory artifacts in cellular signal transduction models.

How does NAD+ compare analytically to NMN and MOTS-c on analytical reports?

NAD+ is a dinucleotide coenzyme with a molecular weight of 663.43 g/mol, whereas NMN is a mononucleotide precursor (334.22 g/mol) and compounds like [MOTS-c research reagent](/product/mots-c-5mg) are multi-amino-acid mitochondrial peptides. Each compound exhibits distinct HPLC retention times, charge profiles, and mass spectral fingerprints on their respective COAs.

Where are PX1 Research NAD+ lots manufactured and tested?

All PX1 Research materials are manufactured within GMP-compliant facilities in the United States and analyzed by independent, ISO 17025 accredited analytical testing laboratories prior to distribution.

How should lyophilized NAD+ powder be stored upon receipt in the lab?

Lyophilized NAD+ should be stored at -20°C in a desiccated container protected from light. Under these conditions, the reagent maintains the purity specifications documented on its COA for extended storage periods.

What solvents are recommended for reconstituting NAD+ for in vitro assays?

NAD+ reconstitutes readily in sterile nuclease-free water or phosphate-buffered saline (PBS). Because aqueous NAD+ is susceptible to temperature- and pH-dependent hydrolysis, stock solutions should be maintained between pH 6.0–7.0, kept on ice during use, and stored in single-use aliquots at -80°C.

Can I obtain a lot-specific NAD+ COA prior to placing a bulk institutional order?

Yes, PX1 Research provides batch-specific COAs for active lots upon request to assist institutional purchasing officers and principal investigators with protocol validation prior to procurement.

What shipping measures protect NAD+ purity during transit?

Orders are dispatched same-day (Monday through Friday) from fulfillment hubs in California and Arizona utilizing temperature-protective packaging to minimize thermal exposure and prevent reagent degradation.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.